Focus: Ceribell is a medical device biotech specializing in rapid EEG (electroencephalogram) systems for neurological monitoring, particularly in intensive care and acute neurology settings. The company operates at the intersection of neurology and ophthalmology with a focus on point-of-care diagnostic devices.
Profile data last refreshed 54m ago · AI intelligence enriched 1mo ago
Cooling — net -7 jobs in 30d
14 added, 21 removed. Slower than typical.
Ceribell is a commercial-stage medical device company with strong hiring momentum, best suited for go-to-market, clinical operations, and device commercialization roles rather than drug discovery-focused careers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ceribell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ceribell's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis - GlobeNewswire
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis GlobeNewswire
CeriBell Q2 revenue rises 33%, raises FY26 guidance to $114M-$117M - scanx.trade
CeriBell Q2 revenue rises 33%, raises FY26 guidance to $114M-$117M scanx.trade
Ceribell Wins FDA Clearance for New AI Enhancements to Neurology Portal - Yahoo Finance
Ceribell Wins FDA Clearance for New AI Enhancements to Neurology Portal Yahoo Finance
Ceribell Secures CMS New Technology Add-On Payment (NTAP) - GlobeNewswire
Ceribell Secures CMS New Technology Add-On Payment (NTAP) GlobeNewswire
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles